Hosted on MSN9mon
A Drug Half as Good as Ozempic for One-30th the Price
When phentermine is prescribed along with another older drug called topiramate—they’re sold in combination as Qsymia—the effect is stronger: more than 9 percent additional weight loss as ...
pharmaphorum7y
FDA approves Qsymia, weight-loss drug for US
Qsymia is a combination of two FDA-approved drugs, phentermine and topiramate, in an extended-release formulation. Two randomised, placebo-controlled clinical trials evaluated the safety and ...
Morningstar6d
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025
QSYMIA is a combination of phentermine, a sympathomimetic amine anorectic, and topiramate, indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess ...
Medscape3y
Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
Objective: To evaluate over 108 weeks the effect of phentermine and topiramate extended release (PHEN/TPM ER) treatment on progression to type 2 diabetes and/or cardiometabolic disease in subjects ...
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025
VIVUS will be discussing its significant 2024 momentum during the J.P. Morgan Healthcare Conference, with an emphasis on what we as a company aim to achieve during the coming months around our novel ...
Yahoo Finance5d
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025
QSYMIA ® (phentermine and topiramate extended-release capsules CIV) Label Update (October 23, 2024): The label for QSYMIA was updated to remove specific body mass index (BMI) requirements and ...